• RRAM-Neuromorphic Synergy Validated: confirmed performance gains of up to 10x for robotics and exoskeleton edge-intelligence applications.
• 22-nm Pathway De-Risked: all three candidate RRAM material stacks passed BEOL compatibility testing.
• RRAM Stability Confirmed: stable performance up to 150°C under automotive-grade conditions.
• Sensor Count and Battery Life Gains Modelled: projected reductions in sensor count and wireless data volume, and increased battery life.
• Healthy Balance Sheet: cash balance of $2.1m as of 30 June 2026.

Dorsavi Ltd (ASX: DVL) has released its Quarterly Activities Report for the quarter ended 30 June 2026, highlighting several key milestones in its RRAM and neuromorphic technology program. The company confirmed the synergy between its RRAM platform and neuromorphic IP, projecting performance gains of up to 10x for robotics and exoskeleton applications. Additionally, all three candidate RRAM material stacks passed Back-End-of-Line (BEOL) compatibility testing, paving the way for the 22nm design phase in H2 2027. RRAM cells demonstrated stable performance up to 150°C under automotive-grade conditions, with zero thermal degradation. Technical analysis also projected a reduction in sensor count by 25-50%, a 10-100x reduction in wireless data volume, and more than double battery life. Dorsavi completed the design of its first integrated RRAM-CMOS validation chip, developed with NTU Singapore and ITRI Taiwan, and reinforced its exoskeleton and robotics strategy with several complementary announcements during the quarter. As of 30 June 2026, Dorsavi held a cash balance of $2.1 million.